BioSenic S.A. (EBR:BIOS)
Belgium flag Belgium · Delayed Price · Currency is EUR
0.0020
0.00 (0.00%)
May 26, 2026, 10:35 AM CET

BioSenic Income Statement

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
24,0969.0511.060.270.31
Revenue Growth (YoY)
266233.24%-18.21%4058.42%-14.74%-91.49%
Gross Profit
24,0969.0511.060.270.31
Selling, General & Admin
---1.550.57
Depreciation & Amortization Expenses
348.423.14--
Research & Development
---1.030.62
Other Operating Expenses
3,2259.651.650-
Total Operating Expenses
3,57312.755.662.581.19
Operating Income
22,250-3.16-8.2-2.32-0.88
Interest Income
1.690-0.010
Interest Expense
-23.19-1.58--0.74-0.11
Other Non-Operating Income (Expense)
--41.88-1.51-0
Total Non-Operating Income (Expense)
-21.51-43.45-1.51-0.73-0.11
Pretax Income
22,228-46.62-9.71-3.05-0.98
Provision for Income Taxes
0.3-0.0100
Net Income
22,228-46.62-9.7-3.05-0.98
Minority Interest in Earnings
----1.010
Net Income to Common
22,228-46.62-9.7-2.04-0.98
Shares Outstanding (Basic)
65332413712021
Shares Outstanding (Diluted)
65332413712021
Shares Change (YoY)
101.54%136.56%13.98%463.72%81.78%
EPS (Basic)
0.03-0.14-0.21-0.02-0.05
EPS (Diluted)
0.03-0.14-0.21-0.02-0.05
Free Cash Flow
-1.05-3.06-5.41-2.05-1.07
Free Cash Flow Per Share
-0.00-0.01-0.04-0.02-0.05
Gross Margin
100.00%100.00%100.00%100.00%100.00%
Operating Margin
92.34%-34.97%-74.11%-871.43%-281.09%
Profit Margin
92.25%-515.24%-87.69%-1146.24%-315.38%
FCF Margin
-0.00%-33.79%-48.94%-768.80%-341.99%
EBITDA
22,250-2.97-7.95-2.26-0.86
EBITDA Margin
92.34%-32.85%-71.91%-848.87%-276.92%
EBIT
22,250-3.16-8.2-2.32-0.88
EBIT Margin
92.34%-34.97%-74.11%-871.43%-281.09%
Effective Tax Rate
0.00%0.00%-0.07%0.00%0.00%